A Study of Language Interpretation Solutions for People With Breast Cancer

Last updated: February 11, 2025
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Cancer

Treatment

Remote Simultaneous Medical Interpreting/RSMI

Remote Consecutive Video Medical Interpreting/RCVI

Remote Consecutive Medical Interpreting/RCMI

Clinical Study ID

NCT06721065
24-350
  • Ages > 18
  • All Genders

Study Summary

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Phase I Patients

  • Age >=18 years (per EMR)

  • Preferred language for healthcare is Spanish or Mandarin (per self-report)

  • Limited English Proficient; cannot speak English "very well" (per self-report)

  • Diagnosis of Stage I, II, III, or IV breast cancer within the past two months (perEMR)

  • Will be visiting MSK oncologist for the first or second appointment (per EMR)

  • Will be continuing medical oncology visits at MSK (per EMR)

  • Agrees to be audio-recorded (per self-report)

Phase 1 Providers

  • Breast cancer provider who sees patients (e.g., breast oncologists, advancedpractice providers, and/or nurses)

  • Does not speak Spanish and/or Mandarin; providers who speak one language and not theother may participate (e.g., speaks Spanish but not Mandarin) (per self-report)

  • Agrees to be audio-record (per self-report) Phase 2 (clinic staff only; patientparticipants will be drawn from Phase 1)

  • Is a staff member who works/worked in one of the study clinic sites during theperiod of Phase 1 RCT study activities

  • Agrees to be audio-recorded (per self-report)

Exclusion

Exclusion Criteria:

Phase 1 Patients

  • Has significant psychiatric disturbance (i.e., acute psychiatric symptoms)sufficient to preclude completion of the assessments, interviews, or informedconsent (per EMR, patient's care team, or study team)

  • Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient topreclude meaningful informed consent and/or data collection (per EMR, patients, careteam, or study team)

Phase I Providers

  • None

Phase 2 (clinic staff only; Phase 1 patient participants follow above criteria)

  • None

Study Design

Total Participants: 640
Treatment Group(s): 3
Primary Treatment: Remote Simultaneous Medical Interpreting/RSMI
Phase:
Study Start date:
December 02, 2024
Estimated Completion Date:
December 02, 2029

Connect with a study center

  • Memorial Sloan Kettering Basking Ridge (Consent Only)

    Basking Ridge, New Jersey 07920
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Monmouth (Consent Only)

    Middletown, New Jersey 07748
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Bergen (Consent Only)

    Montvale, New Jersey 07645
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Suffolk- Commack (Consent Only)

    Commack, New York 11725
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Westchester (Consent Only)

    Harrison, New York 10604
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York 10065
    United States

    Active - Recruiting

  • Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities)

    New York, New York 10035
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Rockville Centre, New York 11553
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.